FIJ

Fiji Kava Limited

About FIJ

Fiji Kava Ltd (FIJ), an Australian-Fijian medicinal kava health & wellness company, producing natural ?noble kava' products for the natural medicine market, estimated to exceed USD $210 billion by 2026 globally. The Danodan range of CBD products contain USFDA certified hemp and non-palm derived USFDA certified glycerine. As the first foreign company with approval from the Fijian Government to operate in the kava industry. Fiji Kava has established a global leading sustainable and 100% traceable, certified organic supply chain of ?noble kava', ginger and turmeric, supported through partnership throughout the Fiji Islands, including with the iTaukei Trust Fund Board.

Buy Australian shares starting with FIJ. Invest today with a CHESS-sponsored broker!

Sector

Consumer Staples

CEO

Industry

Personal Products

Website

fijikava.com

Market Capitalisation

$2M

Price-earnings ratio

-0.12

Dividend yield

0.00%

High today

$0.00

Low today

$0.00

Open price

$0.00

52-week high

$0.08

52-week low

$0.00

Announcements

FIJ FAQs

How much is one share of Fiji Kava Limited?

One share of Fiji Kava Limited is valued at $0.00.

What is the ticker symbol for Fiji Kava Limited?

The ticker symbol for Fiji Kava Limited is FIJ.

How do I buy FIJ shares in Australia?

To buy FIJ stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in FIJ

What is the 52-week high for Fiji Kava Limited stock?

The Fiji Kava Limited 52-week high stock price is $0.08.

What is the 52-week low for Fiji Kava Limited stock?

The Fiji Kava Limited 52-week low stock price is $0.00.

What is the market capitalisation of Fiji Kava Limited FIJ?

As of 24/03/2023 Fiji Kava Limited has a market cap of $2M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.